Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis

Clinical Cancer Research

Volumn 10, Issue 1 I, 2004, Pages 212-221

  Raza, Shaan M ^a   Fuller, Gregory N ^a   Rhee, Chang Hun ^b   Huang, Suyun ^a   Hess, Kenneth ^a   Zhang, Wei ^a   Sawaya, Raymond ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN E; DEOXYRIBONUCLEASE I; ENDOTHELIN B RECEPTOR; EPHRIN RECEPTOR A1; ESTROGEN SULFOTRANSFERASE; FAS ANTIGEN; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROSTAGLANDIN E RECEPTOR; PROTEIN KINASE B; RAS PROTEIN; RNA POLYMERASE II; SOMATOMEDIN BINDING PROTEIN 1; THROMBOMODULIN; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TYROSINE KINASE RECEPTOR;

APOPTOSIS; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SURVIVAL TIME;

BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; NECROSIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 1642453727     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0155-3     Document Type: Article

References (76)

1. Farber, E. Programmed cell death: necrosis versus apoptosis. Mod. Pathol., 7: 605-609, 1994.
2. Kerr, J. F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol., 105: 13-20, 1971.
3. Hammoud, M. A., Sawaya, R., Shi, W., Thall, P. F., and Leeds, N. E. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J. Neuro-Oncol., 27: 65-73, 1996.
4. Roessler, K., Suchanek, G., Breitschopf, H., Kitz, K., Matula, C., Lassmann, H., and Koos, W. T. Detection of tumor necrosis factor of protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J. Neurosurg., 83: 291-297, 1995.
5. Fuller, G. N., Rhee, C. H., Hess, K. R., Caskey, L. S., Wang, R., Bruner, J. M., Yung, W. K., and Zhang, W. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res., 59: 4228-4232, 1999.
6. Raza, S. M., Lang, F. F., Aggarwal, B. B., Fuller, G. N., Wildrick, D. M., and Sawaya, R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery (Baltimore), 51: 2-13, 2002.
7. Adams, R. H., and Klein, R. Eph receptors and ephrin ligands. essential mediators of vascular development. Trends Cardiovasc. Med., 10: 183-188, 2000.
8. Ahmed, A., Dunk, C., Ahmad, S., and Khaliq, A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta, 21 (Suppl. A): S16-S24, 2000.
9. Airoldi, I., Gri, G., Marshall, J. D., Corcione, A., Facchetti, P., Guglielmino, R., Trinchieri, G., and Pistoia, V. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J. Immunol., 165: 6880-6888, 2000.
10. Akiyoshi, S., Inoue, H., Hanai, J., Kusanagi, K., Nemoto, N., Miyazono, K., and Kawabata, M. c-Ski acts as a transcriptional corepressor in transforming growth factor-β signaling through interaction with smads. J. Biol. Chem., 274: 35269-35277, 1999.
11. Bowlin, T. L., Borcherding, D. R., Edwards, C. K., III, and Mc-Whinney, C. D. Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor α production in vitro and in vivo. Cell. Mol. Biol. (Noisy-Le-Grand), 43: 345-349, 1997.
12. Choi, K. C., Kang, S. K., Tai, C. J., Auersperg, N., and Leung, P. C. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology, 142: 2351-2360, 2001.
13. Dadi, H., Ke, S., and Roifman, C. M. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. Blood, 84: 1579-1586, 1994.
14. Daugas, E., Nochy, D., Ravagnan, L., Loeffler, M., Susin, S. A., Zamzami, N., and Kroemer, G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett., 476: 118-123, 2000.
15. Denecker, G., Vercammen, D., Declercq, W., and Vandenabeele, P. Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci., 58: 356-370, 2001.
16. Easty, D. J., Hill, S. P., Hsu, M. Y., Fallowfield, M. E., Florenes, V. A., Herlyn, M., and Bennett, D. C. Up-regulation of ephrin-A1 during melanoma progression. Int. J. Cancer, 84: 494-501, 1999.
17. Eberl, L. P., Egidy, G., Pinet, F., and Juillerat-Jeanneret, L. Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J. Cardiovasc. Pharmacol., 36: S354-S356, 2000.
18. Falany, J. L., and Falany, C. N. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol. Res., 9: 589-596, 1997.
19. Flory, E., Hoffmeyer, A., Smola, U., Rapp, U. R., and Bruder, J. T. Raf-I kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J. Virol., 70: 2260-2268, 1996.
20. Fowler, D. J., Nicolaides, K. H., and Miell, J. P. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum. Reprod. Update, 6: 495-504, 2000.
21. Gao, Z., Li, B. S., Day, Y. J., and Linden, J. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol. Pharmacol., 59: 76-82, 2001.
22. Gold, M. R., Ingham, R. J., McLeod, S. J., Christian, S. L., Scheid, M. P., Duronio, V., Santos, L., and Matsuuchi, L. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol. Rev., 176: 47-68, 2000.
23. Greene, R. A. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int. J. Fertil. Women's Med., 45: 253-257, 2000.
24. Gruss, H. J. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int. J. Clin. Lab. Res., 26: 143-159, 1996.
25. Hofmeister, R., Khaled, A. R., Benbernou, N., Rajnavolgyi, E., Muegge, K., and Durum, S. K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev., 10: 41-60, 1999.
26. Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., and Fuller, G. N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 25: 55-57, 2000.
27. Jacobson, K. A. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci., 19: 184-191, 1998.
28. Kaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Droge, W., and Schmitz, M. L. Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene, 18: 3213-3225, 1999.
29. Kast, R. E. Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. Int. J. Immunopharmacol., 22: 1001-1006, 2000.
30. Kitaura, J., Asai, K., Maeda-Yamamoto, M., Kawakami, Y., Kikkawa, U., and Kawakami, T. Akt-dependent cytokine production in mast cells. J. Exp. Med., 192: 729-740, 2000.
31. Klaassen, C. D., Liu, L., and Dunn, R. T., II. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chem. Biol. Interact., 109: 299-313, 1998.
32. 2 chain gene in atopic subjects. Int. Arch. Allergy Immunol., 124: 117-120, 2001.
33. Kotov, A., Falany, J. L., Wang, J., and Falany, C. N. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol., 68: 137-144, 1999.
34. Lazaar, A. L., Amrani, Y., Hsu, J., Panettieri, R. A., Jr., Fanslow, W. C., Albelda, S. M., and Pure, E. CD40-mediated signal transduction in human airway smooth muscle. J. Immunol., 161: 3120-3127, 1998.
35. Lin, C. G., Lin, Y. C., Liu, H. W., and Kao, L. S. Characterization of Rab3A, Rab3B and Rab3C: different biochemical properties and intracellular localization in bovine chromaffin cells. J. Biochem. (Tokyo), 324: 85-90, 1997.
36. Lin, T. N., Wang, C. K., Cheung, W. M., and Hsu, C. Y. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab., 20: 387-395, 2000.
37. Los, M., Neubuser, D., Coy, J. F., Mozoluk, M., Poustka, A., and Schulze-Osthoff, K. Functional characterization of DNase X, a novel endonuclease expressed in muscle cells. Biochemistry, 39: 7365-7373, 2600.
38. Ludviksson, B. R., Seegers, D., Resnick, A. S., and Strober, W. The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol., 30: 2101-2111, 2000.
39. McKiernan, C. J., Stabila, P. F., and Macara, I. G. Role of the Rab3A-binding domain in targeting of rabphilin-3A to vesicle membranes of PC12 cells. Mol. Cell. Biol., 16: 4985-4995, 1996.
40. McWhinney, C. D., Dudley, M. W., Bowlin, T. L., Peet, N. P., Schook, L., Bradshaw, M., De, M., Borcherding, D. R., and Edwards, C. K., III. Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor α. Eur. Pharmacol., 310: 209-216, 1996.
41. Melter, M., Reinders, M. E., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., and Briscoe, D. M. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood, 96: 3801-3808, 2000.
42. Menouny, M., Binoux, M., and Babajko, S. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int. J. Cancer, 77: 874-879, 1998.
43. Morawietz, H., Talanow, R., Szibor, M., Rueckschloss, U., Schubert, A., Bartling, B., Darmer, D., and Holtz, J. Regulation of the endothelin system by shear stress in human endothelial cells. J. Physiol. (Cambridge), 525: 761-770, 2000.
44. Morga, E., Faber, C., and Heuschling, P. Stimulation of endothelin B receptor modulates the inflammatory activation of rat astrocytes. J. Neurochem., 74: 603-612, 2000.
45. Mosnier, L. O., Meijers, J. C., and Bouma, B. N. Regulation of fibrinolysis in plasma by TAF1 and protein C is dependent on the concentration of thrombomodulin. Thromb. Haemostasis, 85: 5-11, 2001.
46. Naldini, A., and Carraro, F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J. Cell. Physiol., 181: 448-454, 1999.
47. Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., and Pasquale, E. B. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene, 19: 6043-6052, 2000.
48. Ohana, G., Bar-Yehuda, S., Barer, F., and Fishman, P. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J. Cell. Physiol., 186: 19-23, 2001.
49. Paul, B. Z., Ashby, B., and Sheth, S. B. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br. J. Haematol., 102: 1204-1211, 1998.
50. Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., and Nabel, G. J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Wash. DC), 275: 523-527, 1997.
51. Proietti De Santis, L., Garcia, C. L., Balajee, A. S., Brea Calvo, G. T., Bassi, L., and Palitti, F. Transcription coupled repair deficiency results in increased chromosomal aberrations and apoptotic death in the UV61 cell line, the Chinese hamster homologue of Cockayne's syndrome B. Mutat. Res., 485: 121-132, 2001.
52. Rivera, I., Harhaj, E. W., and Sun, S. C. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J. Biol. Chem., 273: 22382-22388, 1998.
53. Rodriguez, A. M., Rodin, D., Nomura, H., Morton, C. C., Weremowicz, S., and Schneider, M. C. Identification, localization, and expression of two novel human genes similar to deoxyribonuclease I. Genomics, 42: 507-513, 1997.
54. Roifman, C. M., Zhang, J., Chitayat, D., and Sharfe, N. A partial deficiency of interleukin-7R α is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood, 96: 2803-2807, 2000.
55. Rothstein, T. L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res., 10: 245-266, 2000.
56. Salatino, M., Labriola, L., Schillaci, R., Charreau, E. H., and Elizalde, P. V. Mechanisms of cell cycle arrest in response to TGF-β in progestin-dependent and -independent growth of mammary tumors. Exp. Cell Res., 265: 152-166, 2001.
57. Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., and Jacobson, M. A. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem., 275: 4429-4434, 2000.
58. Schonbeck, U., Mach, F., Sukhova, G. K., Herman, M., Graber, P., Kehry, M. R., and Libby, P. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol., 156: 7-14, 2000.
59. Sharma, V. K., Bologa, R. M., Li, B., Xu, G. P., Lagman, M., Hiscock, W., Mouradian, J., Wang, J., Serur, D., Rao, V. K., and Suthanthiran. M. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation (Baltimore), 62: 1860-1866, 1996.
60. 2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol., 61: 1153-1160, 2001.
61. Shirakawa, K., Tsuda, H., Heike, Y., Kato, K., Asada, R., Inomata, M., Sasaki, H., Kasumi, F., Yoshimoto, M., Iwanaga, T., Konishi, F., Terada, M., and Wakasugi, H. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res., 61: 445-451, 2001.
62. Shneyvays, V., Jacobson, K. A., Li, A. H., Nawrath, H., Zinman, T., Isaac, A., and Shainberg, A. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Exp. Cell Res., 257: 111-126, 2000.
63. Simpson, R. B., Chase, C. C., Jr., Spicer, L. J., Carroll, J. A., Hammond, A. C., and Welsh. T. H., Jr. Effect of exogenous estradiol on plasma concentrations of somatotropin, insulin-like growth factor-1, insulin-like growth factor binding protein activity, and metabolites in ovariectomized Angus and Brahman cows. Domest. Anim. Endocrinol., 14: 367-380, 1997.
64. Sokolovsky, M., Ambar, I., and Galron, R. A novel subtype of endothelin receptors. J. Biol. Chem., 267: 20551-20554, 1992.
65. 2 receptor. J. Clin. Investig., 103: 1539-1545, 1999.
66. Venkitaraman, A. R., and Cowling, R. J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α chain of the interleukin-7 receptor. Eur. J. Immunol., 24: 2168-2174, 1994.
67. 2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway. Surgery (St. Louis), 114: 314-323, 1993.
68. Xu, H., Zhang, G. X., Wysocka, M., Wu, C. Y., Trinchieri, G., and Rostami, A. The suppressive effect of TGF-β on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): a mechanism involved in inhibition of both IL-12 receptor β1 and β2. J. Neuroimmunol., 108: 53-63, 2000.
69. Yabkowitz, R., Meyer, S., Black, T., Elliott, G., Merewether, L. A., and Yamane, H. K. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood, 93: 1969-1979, 1999.
70. Yue, Y., Su, J., Cerretti, D. P., Fox, G. M., Jing, S., and Zhou, R. Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5. J. Neurosci., 19: 10026-10035, 1999.
71. Zhou, R. The Eph family receptors and ligands. Pharmacol. Ther., 77: 151-181, 1998.
72. Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., Vincenti, V., Granger, H. J., Viglietto, G., and Persico, M. G. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Investig., 76: 517-531, 1997.
73. Chang, F., Steelman, L. S., and McCubrey, J. A. Raf-induced cell cycle progression in human TF-1 hematopoietic cells. Cell Cycle, 1: 220-226, 2002.
74. Green, C. J., Lichtlen, P., Huynh, N. T., Yanovsky, M., Laderoute, K. R., Schaffner, W., and Murphy, B. J. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res., 61: 2696-2703, 2001.
75. Nomura, M., Yamagishi, S., Harada, S., Yamashima, T., Yamashita, J., and Yamamoto, H. Placenta growth factor (P1GF) mRNA expression in brain tumors. J. Neuro-Oncol., 40: 123-130, 1998.
76. Shinagawa, T., Dong, H. D., Xu, M., Maekawa, T., and Ishii, S. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice. EMBO J., 19: 2280-2291, 2000.